- Home
- EVOK vs NVVE Comparison
EVOK vs NVVE Comparison
Compare EVOK & NVVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- NVVE
- Stock Information
- Founded
- EVOK 2007
- NVVE 1996
- Country
- EVOK United States
- NVVE United States
- Employees
- EVOK N/A
- NVVE N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- NVVE Oil Refining/Marketing
- Sector
- EVOK Health Care
- NVVE Energy
- Exchange
- EVOK Nasdaq
- NVVE Nasdaq
- Market Cap
- EVOK 4.3M
- NVVE 3.5M
- IPO Year
- EVOK 2013
- NVVE N/A
- Fundamental
- Price
- EVOK $4.41
- NVVE $3.34
- Analyst Decision
- EVOK
- NVVE
- Analyst Count
- EVOK 0
- NVVE 0
- Target Price
- EVOK N/A
- NVVE N/A
- AVG Volume (30 Days)
- EVOK 1.2M
- NVVE 19.2K
- Earning Date
- EVOK 11-07-2024
- NVVE 11-12-2024
- Dividend Yield
- EVOK N/A
- NVVE N/A
- EPS Growth
- EVOK N/A
- NVVE N/A
- EPS
- EVOK N/A
- NVVE N/A
- Revenue
- EVOK $8,617,036.00
- NVVE $5,144,831.00
- Revenue This Year
- EVOK $124.10
- NVVE $200.61
- Revenue Next Year
- EVOK $75.70
- NVVE $109.43
- P/E Ratio
- EVOK N/A
- NVVE N/A
- Revenue Growth
- EVOK 100.35
- NVVE N/A
- 52 Week Low
- EVOK $3.54
- NVVE $3.18
- 52 Week High
- EVOK $17.40
- NVVE $86.00
- Technical
- Relative Strength Index (RSI)
- EVOK 40.54
- NVVE 39.58
- Support Level
- EVOK $4.28
- NVVE $3.18
- Resistance Level
- EVOK $4.79
- NVVE $4.02
- Average True Range (ATR)
- EVOK 0.45
- NVVE 0.24
- MACD
- EVOK -0.13
- NVVE 0.02
- Stochastic Oscillator
- EVOK 22.82
- NVVE 16.67
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.